All In MedTech

Device Trial Radar · NCT01115465

Study of Macroplastique Safety and Effectiveness in the Treatment of Female Stress Urinary Incontinence

Real-time Observation of Safety and Effectiveness in the Treatment of Female Stress Urinary Incontinence

Last checked: Nov 20, 2026Latest source record: Mar 11, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

276

Actual

Start

Jan 2008

Primary completion

Dec 2021

Study completion Feb 2022

Sponsor

Lead sponsor
Uroplasty, IncNot on our public-company list
Sponsor type
Industry
First posted
May 4, 2010

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The ROSE Registry will determine the long-term safety and effectiveness of Macroplastique in the treatment of female stress urinary incontinence (SUI) due to intrinsic sphincter deficiency (ISD).

Conditions

  • Stress Urinary Incontinence

Interventions

  • MacroplastiqueDevice

    Macroplastique is an injectable soft-tissue bulking agent used to treat stress urinary incontinence (SUI) primarily due to intrinsic sphincter deficiency (ISD).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To describe the incidence of additional or alternative treatment for stress urinary incontinence due to ISD following up to two Macroplastique treatments over a 5 year period.Time frame: 5-years

Locations

19 sites in 1 country. Site status is shown where the registry gives one.

  • Urological Associates of Southern Arizona

    Tucson, Arizona

  • Kaiser Permanente Southern California-Irvine Medical Center

    Irvine, California

  • Univeristy of California- Irvine

    Orange, California

16 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.